Efficacy and safety of ripretinib in patients with KIT-altered metastatic melanoma

por Janku, F., Bauer, S., Shoumariyeh, K., Jones, R.L., Spreafico, A., Jennings, J., Psoinos, C., Meade, J., Ruiz-Soto, R., Chi, P.
Publicado 2022